Arnoud V. Hof - Publications

Outcomes in octogenarians undergoing percutaneous coronary intervention: nationwide data from the Netherlands Heart Registration.

Journal: Journal of geriatric cardiology : JGC

Published: March 04, 2026

Diffuse coronary artery disease leads to deferral of both surgical and percutaneous coronary artery revascularisation.

Journal: International journal of cardiology

Published: September 25, 2025

Current and Future Roles of Glycoprotein IIb-IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction.

Journal: Biomedicines

Published: July 23, 2024

Outcomes with P2Y12 inhibitor monotherapy after PCI according to bleeding risk: A Bayesian meta-analysis.

Journal: Cardiovascular revascularization medicine : including molecular interventions

Published: September 22, 2022

Permanent pacemaker implantation following transcatheter aortic valve implantation using self-expandable, balloon-expandable, or mechanically expandable devices: a network meta-analysis.

Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Published: March 18, 2021

Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands: A Multicenter Pilot Registry.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: August 13, 2020

Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitors.

Journal: Journal of cardiovascular medicine (Hagerstown, Md.)

Published: March 23, 2013

Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitors.

Journal: Archives of cardiovascular diseases

Published: October 24, 2012